Comparative Analysis of Serum Proteins Between Hepatitis B Virus Genotypes B and C Infection by DIA-Based Quantitative Proteomics

References

• Seto WK, Lo YR, Pawlotsky JM, et al. Chronic hepatitis B virus infection. Lancet. 2018;392(10161):2313–2324. doi:10.1016/S0140-6736(18)31865-8.30496122
   PubMed Web of Science ®Google Scholar
• Yuen MF, Chen DS, Dusheiko GM, et al. Hepatitis B virus infection. Nat Rev Dis Primers. 2018;4:18035. doi:10.1038/nrdp.2018.35.29877316
   PubMed Web of Science ®Google Scholar
• Hepatitis B: key facts. Geneva: World Health Organization; 2020 Available from: https://www.who.int/en/news-room/fact-sheets/detail/hepatitis-b. Accessed October 29, 2021.
   Google Scholar
• Gao Q, Zhu H, Dong L, et al. Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma. Cell. 2019;179(2):561–577.e22. doi:10.1016/j.cell.2019.08.052.31585088
   PubMed Web of Science ®Google Scholar
• Sunbul M. Hepatitis B virus genotypes: global distribution and clinical importance. World J Gastroenterol. 2014;20(18):5427–5434. doi:10.3748/wjg.v20.i18.5427.24833873
   PubMed Web of Science ®Google Scholar
• Velkov S, Protzer U, Michler T. Global Occurrence of Clinically Relevant Hepatitis B Virus Variants as Found by Analysis of Publicly Available Sequencing Data. Viruses. 2020;12(11):1344. doi:10.3390/v12111344.
   Web of Science ®Google Scholar
• Lin CL, Kao JH. Natural history of acute and chronic hepatitis B: the role of HBV genotypes and mutants. Best Pract Res Clin Gastroenterol. 2017;31(3):249–255. doi:10.1016/j.bpg.2017.04.010.28774406
   PubMed Web of Science ®Google Scholar
• Liu J, Liang W, Jing W, et al. Countdown to 2030: eliminating hepatitis B disease, China. Bull World Health Organ. 2019;97(3):230–238. doi:10.2471/BLT.18.219469.30992636
   PubMed Web of Science ®Google Scholar
• Wei DH, Liu HZ, Huang AM, et al. A new trend of genotype distribution of hepatitis B virus infection in southeast China (Fujian), 2006–2013. Epidemiol Infect. 2015;143(13):2822–2826. doi:10.1017/S0950268815000059.25648505
   PubMed Web of Science ®Google Scholar
• An P, Xu J, Yu Y, et al. Host and Viral Genetic Variation in HBV-Related Hepatocellular Carcinoma. Front Genet. 2018;9:261. doi:10.3389/fgene.2018.00261.30073017
   PubMed Web of Science ®Google Scholar
• Lin CL, Kao JH. Hepatitis B virus genotypes and variants. Cold Spring Harb Perspect Med. 2015;5(5):a021436. doi:10.1101/cshperspect.a021436.25934462
   PubMed Web of Science ®Google Scholar
• Pujol F, Jaspe RC, Loureiro CL, et al. Hepatitis B virus American genotypes: pathogenic variants? Clin Res Hepatol Gastroenterol. 2020;44(6):825–835. doi:10.1016/j.clinre.2020.04.018.32553521
   PubMed Web of Science ®Google Scholar
• Kao JH, Chen PJ, Lai MY, et al. Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers. Gastroenterology. 2003;124(2):327–334. doi:10.1053/gast.2003.50053.12557138
   PubMed Web of Science ®Google Scholar
• Zhao J, Guo Y, Yan Z, et al. The natural YMDD mutations of hepatitis B virus in Western China. Scand J Infect Dis. 2012;44(1):44–47. doi:10.3109/00365548.2011.598871.21851334
   PubMed Web of Science ®Google Scholar
• Chu CJ, Hussain M, Lok AS. Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C. Gastroenterology. 2002;122(7):1756–1762. doi:10.1053/gast.2002.33588.12055581
   PubMed Web of Science ®Google Scholar
• Xibing G, Xiaojuan Y, Juanhua W, et al. Relationship between HBV genotypes B, C and follicular helper T cells in patients with chronic hepatitis B and its significance. Hepat Mon. 2013;13(1):e6221. doi:10.5812/hepatmon.6221.23585765
   PubMed Web of Science ®Google Scholar
• Haga H, Saito T, Okumoto K, et al. Incidence of development of hepatocellular carcinoma in Japanese patients infected with hepatitis B virus is equivalent between genotype B and C in long term. J Viral Hepat. 2019;26(7):866–872. doi:10.1111/jvh.13099.30924226
   PubMed Web of Science ®Google Scholar
• Wai CT, Chu CJ, Hussain M, et al. HBV genotype B is associated with better response to interferon therapy in HBeAg(+) chronic hepatitis than genotype C. Hepatology. 2002;36(6):1425–1430. doi:10.1053/jhep.2002.37139.12447868
   PubMed Web of Science ®Google Scholar
• Mitra B, Thapa RJ, Guo H, et al. Host functions used by hepatitis B virus to complete its life cycle: implications for developing host-targeting agents to treat chronic hepatitis B. Antiviral Res. 2018;158:185–198. doi:10.1016/j.antiviral.2018.08.014.30145242
   PubMed Web of Science ®Google Scholar
• Wei D, Zhang X. Proteomic analysis of interactions between a deep-sea thermophilic bacteriophage and its host at high temperature. J Virol. 2010;84(5):2365–2373. doi:10.1128/JVI.02182-09.20015994
   PubMed Web of Science ®Google Scholar
• Tong S, Revill P. Overview of hepatitis B viral replication and genetic variability. J Hepatol. 2016;64(1 Suppl):S4–S16. doi:10.1016/j.jhep.2016.01.027.27084035
   PubMed Web of Science ®Google Scholar
• Saxena R, Kaur J. Th1/Th2 cytokines and their genotypes as predictors of hepatitis B virus related hepatocellular carcinoma. World J Hepatol. 2015;7(11):1572–1580. doi:10.4254/wjh.v7.i11.1572.26085916
   PubMedGoogle Scholar
• Yuen MF, Wong DK, Zheng BJ, et al. Difference in T helper responses during hepatitis flares in hepatitis B e antigen (HBeAg)-positive patients with genotypes B and C: implication for early HBeAg seroconversion. J Viral Hepat. 2007;14(4):269–275. doi:10.1111/j.1365-2893.2006.00799.x.17381719
   PubMed Web of Science ®Google Scholar
• Han YF, Zhao J, Ma LY, et al. Factors predicting occurrence and prognosis of hepatitis-B-virus-related hepatocellular carcinoma. World J Gastroenterol. 2011;17(38):4258–4270. doi:10.3748/wjg.v17.i38.4258.22090781
   PubMed Web of Science ®Google Scholar
• Wei D, Zeng Y, Xing X, et al. Proteome Differences between Hepatitis B Virus Genotype-B- and Genotype-C-Induced Hepatocellular Carcinoma Revealed by iTRAQ-Based Quantitative Proteomics. J Proteome Res. 2016;15(2):487–498. doi:10.1021/acs.jproteome.5b00838.26709725
   PubMed Web of Science ®Google Scholar
• Khodadadi E, Zeinalzadeh E, Taghizadeh S, et al. Proteomic Applications in Antimicrobial Resistance and Clinical Microbiology Studies. Infect Drug Resist. 2020;13:1785–1806. doi:10.2147/IDR.S238446.32606829
   PubMed Web of Science ®Google Scholar
• Huang J, Yin X, Zhang L, et al. Serum proteomic profiling in patients with advanced Schistosoma japonicum-induced hepatic fibrosis. Parasit Vectors. 2021;14(1):232. doi:10.1186/s13071-021-04734-1.33933138
   PubMed Web of Science ®Google Scholar
• Shen Y, Xun J, Song W, et al. Discovery of Potential Plasma Biomarkers for Tuberculosis in HIV-Infected Patients by Data-Independent Acquisition-Based Quantitative Proteomics. Infect Drug Resist. 2020;13:1185–1196. doi:10.2147/IDR.S245460.32425558
   PubMed Web of Science ®Google Scholar
• Sajic T, Liu Y, Aebersold R. Using data-independent, high-resolution mass spectrometry in protein biomarker research: perspectives and clinical applications. Proteomics Clin Appl. 2015;9(3–4):307–321. doi:10.1002/prca.201400117.25504613
   PubMed Web of Science ®Google Scholar
• Bruderer R, Muntel J, Müller S, et al. Analysis of 1508 Plasma Samples by Capillary-Flow Data-Independent Acquisition Profiles Proteomics of Weight Loss and Maintenance. Mol Cell Proteomics. 2019;18(6):1242–1254. doi:10.1074/mcp.RA118.001288.30948622
   PubMed Web of Science ®Google Scholar
• Takaya H, Kawaratani H, Tsuji Y, et al. von Willebrand factor is a useful biomarker for liver fibrosis and prediction of hepatocellular carcinoma development in patients with hepatitis B and C. United Eur Gastroenterol J. 2018;6(9):1401–1409. doi:10.1177/2050640618779660.
   Web of Science ®Google Scholar
• Wang Y, Gallant RC, Ni H. Extracellular matrix proteins in the regulation of thrombus formation. Curr Opin Hematol. 2016;23(3):280–287. doi:10.1097/MOH.0000000000000237.26871252
   PubMed Web of Science ®Google Scholar
• Bubeck D, Roversi P, Donev R, et al. Structure of human complement C8, a precursor to membrane attack. J Mol Biol. 2011;405(2):325–330. doi:10.1016/j.jmb.2010.10.031.21073882
   PubMed Web of Science ®Google Scholar
• Kramvis A. Genotypes and genetic variability of hepatitis B virus. Intervirology. 2014;57(3–4):141–150. doi:10.1159/000360947.25034481
   PubMed Web of Science ®Google Scholar
• Biswas B, Kandpal M, Vivekanandan PA. G-quadruplex motif in an envelope gene promoter regulates transcription and virion secretion in HBV genotype B. Nucleic Acids Res. 2017;45(19):11268–11280. doi:10.1093/nar/gkx823.28981800
   PubMed Web of Science ®Google Scholar
• Murphy S, Zweyer M, Mundegar RR, et al. Proteomic serum biomarkers for neuromuscular diseases. Expert Rev Proteomics. 2018;15(3):277–291. doi:10.1080/14789450.2018.1429923.29338453
   PubMed Web of Science ®Google Scholar
• Chen Y, Huang A, Ao W, et al. Proteomic analysis of serum proteins from HIV/AIDS patients with Talaromyces marneffei infection by TMT labeling-based quantitative proteomics. Clin Proteomics. 2018;15:40. doi:10.1186/s12014-018-9219-8.30598657
   PubMed Web of Science ®Google Scholar
• Conway EM. Complement-coagulation connections. Blood Coagul Fibrinolysis. 2018;29(3):243–251. doi:10.1097/MBC.0000000000000720.29517503
   PubMed Web of Science ®Google Scholar
• Qin X, Gao B. The complement system in liver diseases. Cell Mol Immunol. 2006;3(5):333–340.17092430
   PubMed Web of Science ®Google Scholar
• Mellors J, Tipton T, Longet S, et al. Viral Evasion of the Complement System and Its Importance for Vaccines and Therapeutics. Front Immunol. 2020;11:1450. doi:10.3389/fimmu.2020.01450.32733480
   PubMed Web of Science ®Google Scholar
• Ling M, Murali M. Analysis of the Complement System in the Clinical Immunology Laboratory. Clin Lab Med. 2019;39(4):579–590. doi:10.1016/j.cll.2019.07.006.31668271
   PubMed Web of Science ®Google Scholar
• Nag J, Mukesh RK, Suma SM, et al. A Factor I-Like Activity Associated with Chikungunya Virus Contributes to Its Resistance to the Human Complement System. J Virol. 2020;94(7):e02062–19. doi:10.1128/JVI.02062-19.31941783
   PubMed Web of Science ®Google Scholar
• Feng S, Liang X, Kroll MH, et al. von Willebrand factor is a cofactor in complement regulation. Blood. 2015;125(6):1034–1037. doi:10.1182/blood-2014-06-585430.25395424
   PubMed Web of Science ®Google Scholar
• Turner NA, Moake J. Assembly and activation of alternative complement components on endothelial cell-anchored ultra-large von Willebrand factor links complement and hemostasis-thrombosis. PLoS One. 2013;8(3):e59372. doi:10.1371/journal.pone.0059372.23555663
   PubMed Web of Science ®Google Scholar
• Nolasco JG, Nolasco LH, Da Q, et al. Complement Component C3 Binds to the A3 Domain of von Willebrand Factor. TH Open. 2018;2(3):e338–e345. doi:10.1055/s-0038-1672189.31080944
   PubMedGoogle Scholar
• Takaya H, Namisaki T, Kitade M, et al. VWF/ADAMTS13 ratio as a potential biomarker for early detection of hepatocellular carcinoma. BMC Gastroenterol. 2019;19(1):167. doi:10.1186/s12876-019-1082-1.31638892
   PubMed Web of Science ®Google Scholar
• Franc V, Zhu J, Heck AJR. Comprehensive Proteoform Characterization of Plasma Complement Component C8αβγ by Hybrid Mass Spectrometry Approaches. J Am Soc Mass Spectrom. 2018;29(6):1099–1110. doi:10.1007/s13361-018-1901-6.29532326
   PubMed Web of Science ®Google Scholar
• Zhang Y, Chen X, Cao Y, et al. C8B in Complement and Coagulation Cascades Signaling Pathway is a predictor for Survival in HBV-Related Hepatocellular Carcinoma Patients. Cancer Manag Res. 2021;13:3503–3515. doi:10.2147/CMAR.S302917.33911900
   PubMed Web of Science ®Google Scholar